Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 1/10

vs
industry
vs
history
Cash to Debt No Debt
HH's Cash to Debt is ranked higher than
99% of the 264 Companies
in the Global Medical Care industry.

( Industry Median: 0.14 vs. HH: No Debt )
Ranked among companies with meaningful Cash to Debt only.
HH' s 10-Year Cash to Debt Range
Min: 0.01   Max: No Debt
Current: No Debt

Equity to Asset 0.31
HH's Equity to Asset is ranked lower than
51% of the 264 Companies
in the Global Medical Care industry.

( Industry Median: 0.33 vs. HH: 0.31 )
Ranked among companies with meaningful Equity to Asset only.
HH' s 10-Year Equity to Asset Range
Min: 0.31   Max: 0.92
Current: 0.31

0.31
0.92
F-Score: 3
Z-Score: -16.37
M-Score: -3.92
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 2/10

vs
industry
vs
history
Operating margin (%) -18.18
HH's Operating margin (%) is ranked lower than
73% of the 264 Companies
in the Global Medical Care industry.

( Industry Median: 4.30 vs. HH: -18.18 )
Ranked among companies with meaningful Operating margin (%) only.
HH' s 10-Year Operating margin (%) Range
Min: -50.4   Max: 15.39
Current: -18.18

-50.4
15.39
Net-margin (%) -29.35
HH's Net-margin (%) is ranked lower than
73% of the 264 Companies
in the Global Medical Care industry.

( Industry Median: 1.45 vs. HH: -29.35 )
Ranked among companies with meaningful Net-margin (%) only.
HH' s 10-Year Net-margin (%) Range
Min: -46.65   Max: 8.77
Current: -29.35

-46.65
8.77
ROE (%) -114.15
HH's ROE (%) is ranked lower than
70% of the 264 Companies
in the Global Medical Care industry.

( Industry Median: 2.16 vs. HH: -114.15 )
Ranked among companies with meaningful ROE (%) only.
HH' s 10-Year ROE (%) Range
Min: -97.35   Max: 27.37
Current: -114.15

-97.35
27.37
ROA (%) -49.29
HH's ROA (%) is ranked lower than
75% of the 264 Companies
in the Global Medical Care industry.

( Industry Median: 1.15 vs. HH: -49.29 )
Ranked among companies with meaningful ROA (%) only.
HH' s 10-Year ROA (%) Range
Min: -69.56   Max: 16.83
Current: -49.29

-69.56
16.83
ROC (Joel Greenblatt) (%) -107.65
HH's ROC (Joel Greenblatt) (%) is ranked lower than
73% of the 264 Companies
in the Global Medical Care industry.

( Industry Median: 8.51 vs. HH: -107.65 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
HH' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -387.05   Max: 210.26
Current: -107.65

-387.05
210.26
Revenue Growth (3Y)(%) -43.90
HH's Revenue Growth (3Y)(%) is ranked lower than
57% of the 264 Companies
in the Global Medical Care industry.

( Industry Median: -12.00 vs. HH: -43.90 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
HH' s 10-Year Revenue Growth (3Y)(%) Range
Min: -47.2   Max: 11.5
Current: -43.9

-47.2
11.5
EPS Growth (3Y)(%) 17.00
HH's EPS Growth (3Y)(%) is ranked higher than
85% of the 264 Companies
in the Global Medical Care industry.

( Industry Median: 0.00 vs. HH: 17.00 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
HH' s 10-Year EPS Growth (3Y)(%) Range
Min: 0   Max: 62
Current: 17

0
62
» HH's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q2 2014

HH Guru Trades in Q2 2014

Jim Simons 784,500 sh (-0.51%)
» More
Q3 2014

HH Guru Trades in Q3 2014

Jim Simons 815,600 sh (+3.96%)
» More
Q4 2014

HH Guru Trades in Q4 2014

Jim Simons 838,200 sh (+2.77%)
» More
Q1 2015

HH Guru Trades in Q1 2015

Jim Simons 849,800 sh (+1.38%)
» More
» Details

Insider Trades

Latest Guru Trades with HH

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/B 7.40
HH's P/B is ranked lower than
87% of the 248 Companies
in the Global Medical Care industry.

( Industry Median: 3.00 vs. HH: 7.40 )
Ranked among companies with meaningful P/B only.
HH' s 10-Year P/B Range
Min: 0.31   Max: 11.4
Current: 7.4

0.31
11.4
P/S 1.10
HH's P/S is ranked higher than
63% of the 264 Companies
in the Global Medical Care industry.

( Industry Median: 1.37 vs. HH: 1.10 )
Ranked among companies with meaningful P/S only.
HH' s 10-Year P/S Range
Min: 0.06   Max: 2.03
Current: 1.1

0.06
2.03
Current Ratio 1.15
HH's Current Ratio is ranked higher than
57% of the 264 Companies
in the Global Medical Care industry.

( Industry Median: 0.97 vs. HH: 1.15 )
Ranked among companies with meaningful Current Ratio only.
HH' s 10-Year Current Ratio Range
Min: 1.15   Max: 9.6
Current: 1.15

1.15
9.6
Quick Ratio 1.04
HH's Quick Ratio is ranked higher than
57% of the 264 Companies
in the Global Medical Care industry.

( Industry Median: 0.87 vs. HH: 1.04 )
Ranked among companies with meaningful Quick Ratio only.
HH' s 10-Year Quick Ratio Range
Min: 1.04   Max: 9.6
Current: 1.04

1.04
9.6
Days Inventory 16.41
HH's Days Inventory is ranked higher than
74% of the 264 Companies
in the Global Medical Care industry.

( Industry Median: 69.61 vs. HH: 16.41 )
Ranked among companies with meaningful Days Inventory only.
HH' s 10-Year Days Inventory Range
Min: 2.38   Max: 19.37
Current: 16.41

2.38
19.37
Days Sales Outstanding 66.05
HH's Days Sales Outstanding is ranked lower than
54% of the 264 Companies
in the Global Medical Care industry.

( Industry Median: 59.97 vs. HH: 66.05 )
Ranked among companies with meaningful Days Sales Outstanding only.
HH' s 10-Year Days Sales Outstanding Range
Min: 35.67   Max: 126.82
Current: 66.05

35.67
126.82

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 7.40
HH's Price/Tangible Book is ranked lower than
53% of the 264 Companies
in the Global Medical Care industry.

( Industry Median: 6.60 vs. HH: 7.40 )
Ranked among companies with meaningful Price/Tangible Book only.
HH' s 10-Year Price/Tangible Book Range
Min: 0.44   Max: 12.94
Current: 7.4

0.44
12.94
Price/Median PS Value 2.10
HH's Price/Median PS Value is ranked lower than
86% of the 264 Companies
in the Global Medical Care industry.

( Industry Median: 1.20 vs. HH: 2.10 )
Ranked among companies with meaningful Price/Median PS Value only.
HH' s 10-Year Price/Median PS Value Range
Min: 0.17   Max: 8.17
Current: 2.1

0.17
8.17
Earnings Yield (Greenblatt) -18.00
HH's Earnings Yield (Greenblatt) is ranked lower than
81% of the 264 Companies
in the Global Medical Care industry.

( Industry Median: 3.20 vs. HH: -18.00 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) only.
HH' s 10-Year Earnings Yield (Greenblatt) Range
Min: -18   Max: 9.7
Current: -18

-18
9.7
Forward Rate of Return (Yacktman) 76.26
HH's Forward Rate of Return (Yacktman) is ranked higher than
99% of the 264 Companies
in the Global Medical Care industry.

( Industry Median: 0.00 vs. HH: 76.26 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) only.
HH' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -12   Max: 11.2
Current: 76.26

-12
11.2

Business Description

Industry: Health Care Providers » Medical Care
Compare:CHE, DVA, FSNUY, BDUUF, SKHCY » details
Hooper Holmes Inc was founded in 1899. The Company provides health risk assessment services. The Company along with its subsidiaries mobilizes a network of health professionals to provide on-site health screenings, laboratory testing, risk assessment and sample collection services to wellness and disease management companies, insurance companies, employers, government organizations and academic institutions. The Company also conducts laboratory testing, assembles collection kits, conducts telephone interviews of life insurance applicants, compiles health histories, collects medical records and provides underwriting services to help life insurance companies evaluate underwriting risks. It is currently engaged in the following segments; Health and Wellness, Heritage Labs, Hooper Holmes Services. Health and Wellness, performs risk assessment and risk management services, including biometric screenings, health risk assessments and onsite wellness coaching for health and care management companies, including wellness companies, disease management organizations, clinical research organizations and, health plans as they manage the health services of corporate and government employees. Heritage Labs performs tests of blood, urine and oral fluid specimens, primarily generated in connection with the paramedical exams and wellness screenings performed by third party paramedical service providers and its Health and Wellness segment, respectively, and assembles and sells specimen collection kits. The Hooper Holmes Services provides telephone interviews of insurance candidates, retrieval of medical records and inspections, risk management solutions and underwriting services for simplified issue products and products requiring full underwriting on behalf of insurance companies. All of the segments particularly health screenings and lab services of the Company are subject to federal and state regulation.
» More Articles for HH

Headlines

Articles On GuruFocus.com
Arquitos Capital Management Q1 2015 Investor Letter May 01 2015 
comment on HH Jun 18 2011 
Hooper Holmes Inc Reports Operating Results (10-Q) Nov 05 2010 
Hooper Holmes Inc Reports Operating Results (10-Q) Aug 06 2010 
Hooper Holmes Inc Reports Operating Results (10-Q) May 07 2010 
Hooper Holmes Inc Reports Operating Results (10-Q) Nov 06 2009 
Hooper Holmes Inc (HH) CEO Roy H Bubbs buys 50,000 Shares Aug 14 2009 
Hooper Holmes Inc Reports Operating Results (10-Q) Aug 07 2009 
Hooper Holmes Inc (HH) CEO Roy H Bubbs buys 25,326 Shares Jun 01 2009 
Hooper Holmes Inc (HH) CEO Roy H Bubbs buys 31,577 Shares May 29 2009 

More From Other Websites
HOOPER HOLMES INC Financials May 27 2015
HOOPER HOLMES INC Files SEC form 8-K/A, Financial Statements and Exhibits May 21 2015
10-Q for Hooper Holmes, Inc. May 16 2015
Hooper Holmes Announces First Quarter 2015 Financial Results May 14 2015
HOOPER HOLMES INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... May 14 2015
Hooper Holmes Announces First Quarter 2015 Financial Results May 14 2015
Q1 2015 Hooper Holmes Inc Earnings Release - Before Market Open May 14 2015
Hooper Holmes Announces 2015 First-Quarter Earnings Release Date and Conference Call Information May 07 2015
10-K for Hooper Holmes, Inc. Apr 25 2015
HOOPER HOLMES INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion of... Apr 21 2015
Hooper Holmes Acquires Accountable Health Solutions Apr 20 2015
Hooper Holmes Acquires Accountable Health Solutions Apr 20 2015
Hooper Holmes Announces 2014 Financial Results Mar 31 2015
HOOPER HOLMES INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Mar 31 2015
Hooper Holmes Announces 2014 Financial Results Mar 31 2015
Q4 2014 Hooper Holmes Inc Earnings Release - Before Market Open Mar 31 2015
Hooper Holmes Announces 2014 Fourth-Quarter Earnings Release Date and Conference Call Information Mar 26 2015
Hooper Holmes Announces 2014 Fourth-Quarter Earnings Release Date and Conference Call Information Mar 25 2015
HOOPER HOLMES INC Files SEC form 8-K, Change in Directors or Principal Officers Feb 05 2015
Mark Emkjer Appointed to the Board of Directors of Hooper Holmes Feb 05 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK